Two new publications show results on the effectiveness of inhibitors of janus kinases (iJAK) in giant cell arteritis (GCA) and on the effectiveness of the antibody tocilizumab for aortitis in GCA. Researchers from the Immunopathology Group of IDIVAL, led by Dr. Javier Loricera García and Dr. Ricardo Blanco Alonso, have carried out two studies to […]
The meeting of the IDIVAL Nursing research group highlighted the progress and next steps in the pilots it is leading in Cantabria on health literacy, integrated care pathways and self-management of patients with these diseases. On July 2, the Nursing research group of the Marqués de Valdecilla Health Research Institute (IDIVAL), led by Dr. Carmen […]
The Valdecilla Clinical Trials Unit and the Research Support Unit of the Marqués de Valdecilla Research Institute (IDIVAL) have highlighted the importance of specialised talent in supporting the execution of clinical trials. This announcement comes in light of recent findings published in a comprehensive review on challenges and solutions in the field of clinical trials. […]
Next Wednesday, June 5, Dr. Young J. Juhn will visit IDIVAL with the aim of establishing a collaboration with Cohorte Cantabria. Dr. Young J. Juhn is Professor of Pediatrics and Clinical Investigator at the Mayo Clinic. He is currently the Chair of Research at Mayo Clinic Health System and Director of the Artificial Intelligence Program […]
Speakers who are experts in the field of headaches will discuss the latest advances in their diagnosis and treatment Headaches, characterised by recurrent headaches, are one of the most common disorders of the nervous system, affecting people of all ages, races, income levels and geographical areas. It is not only painful but also disabling, as […]
The event will take place on May 21 at IDIVAL’s facilities The Marqués de Valdecilla Health Research Institute (IDIVAL) is organizing a round table discussion entitled “Artificial intelligence: how can we use it in the healthcare environment” on May 21. The initiative will take place in person at the IDIVAL headquarters at 13:30h and will […]
This advisory body meets regularly and ensures the scientific quality of the institute. The members of the External Scientific Council of the Marqués de Valdecilla Health Research Institute (IDIVAL) met last week at IDIVAL and online in order to evaluate the activity of some research groups of the center, as well as to monitor the […]
The conclusions obtained in the research could help design policies to address the difficulties of this type of families. A recent study published in the international Journal of Family and Economic Issues by the Health Economics Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) explored economic circumstances, lifestyle factors (obesity, smoking and alcohol) […]
1.7 million, the project will run until the end of 2025 and will involve leading international institutions in the sector. The FAITHFUL, innovation project consortium, led by the Spanish startup Idoven, thanks to the support of EIT Health, has just launched the development of a technological solution that aims to prevent 4 out of 10 […]
IDIVAL researcher Javier Crespo is coordinating the congress, which will take place on 11th and 12th April The 1st International Symposium on Rare Liver Diseases 2024 will bring together leading national and international experts in the field of rare liver diseases, with the aim of sharing knowledge, scientific advances and clinical experiences relevant to the […]
